Back

Médunik Canada takes exclusive Canadian Diacomit promotion under Biocodex agreement

Verifying
  • Médunik Canada assumes exclusive Canadian sales, marketing and medical affairs for Diacomit.
  • Diacomit is approved with clobazam and valproate for Dravet syndrome seizures.
  • Agreement aims to maintain uninterrupted access for eligible patients across Canada.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.